Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


September 01, 2015 11:21 AM ET

Biotechnology

Company Overview of Cantex Pharmaceuticals, Inc.

Company Overview

Cantex Pharmaceuticals, Inc., a biotechnology company, engages in developing cancer treatments. It offers ODSH, a low anticoagulant heparin derivative that reduces the incidence, severity, and duration of reduction of platelet counts caused by chemotherapy. The company also provides Disulfiram-Copper Chelate that includes non-overlapping cancer stem cell killing mechanisms of actions, including proteasome inhibition, induction of reactive oxygen species, and strong inhibition of ALDH and the NF Kappa B pathways for metastatic breast cancer, pancreatic cancer, and glioblastoma. Cantex Pharmaceuticals, Inc. was formerly known as PARINGENIX INC. The company was incorporated in 2002 and is based...

1792 Bell Tower Lane

Suite 222

Weston, FL 33326

United States

Founded in 2002

Phone:

954-315-3660

Fax:

954-315-3661

Key Executives for Cantex Pharmaceuticals, Inc.

Chairman and Chief Executive Officer
Age: 71
President and Director
Chief Financial Officer
Age: 48
Vice President of Clinical Operations
Compensation as of Fiscal Year 2015.

Cantex Pharmaceuticals, Inc. Key Developments

Cantex Pharmaceuticals Announces Management Appointments

Cantex Pharmaceuticals, Inc. announced key additions to its senior management team that bring strategic experience in finance and clinical operations as the Company advances its corporate and development strategies. New members of the executive management team include Juan F. Rodriguez, Chief Financial Officer, and Karen Ivester, RN, MA, PMP, Vice President of Clinical Operations. Juan Rodriguez brings more than 20 years of financial and business leadership experience to Cantex, the majority of which has been in the life sciences field. Most recently, Mr. Rodriguez served as Chief Financial Officer at OPKO Health, Inc. and has, since 2007, served as Chairman of the Advisory Board of Cognitec Systems GmbH, a German software developer. From 1995 to 2007, prior to its acquisition by Abbott Laboratories, Mr. Rodriguez was with Kos Pharmaceuticals, Inc., a publicly traded, specialty pharmaceutical company engaged in the development and commercialization of proprietary prescription products. Karen Ivester has 28 years' experience managing clinical trials, including 14 years' direct experience in oncology therapeutics. Prior to Cantex, Ms. Ivester held the positions of Head Early Phase Oncology, Solid Tumor Division for Quintiles; Director, Global Hematology/Oncology Group at Pharmaceutical Product Development (PPD-CRO); Senior Portfolio Director, Account and Partnership Management at PAREXEL; and Senior Project Manager at Quintiles Transnational.

Cantex Pharmaceuticals, Inc. Presents at Needham & Company's 14th Annual Healthcare Conference, Apr-14-2015 10:40 AM

Cantex Pharmaceuticals, Inc. Presents at Needham & Company's 14th Annual Healthcare Conference, Apr-14-2015 10:40 AM. Venue: Westin Grand Central Hotel, New York, New York, United States.

Cantex Pharmaceuticals, Inc. Presents at BioFlorida Annual Conference, Oct-14-2014 11:15 AM

Cantex Pharmaceuticals, Inc. Presents at BioFlorida Annual Conference, Oct-14-2014 11:15 AM. Venue: Harbor Beach Marriott, Ft. Lauderdale, Florida, United States. Speakers: Stephen Marcus, President and Director.

Similar Private Companies By Industry

Company Name Region
Adimab, LLC United States
CLINIQA Corporation United States
Abviva, Inc. United States
Vivonics, Inc. United States
InteKrin Therapeutics Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Cantex Pharmaceuticals, Inc., please visit www.cantex.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.